Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Macrobian Biotech logo — Towards Novel Treatments for Parkinson's Disease

Macrobian Biotech

Towards Novel Treatments for Parkinson's Disease

Founded 2017 The Netherlands The Netherlands 2 employees Pre-Seed Biotechnology, Health Care

General Information

Company Name Macrobian Biotech
Founded Year 2017
Location The Netherlands The Netherlands
Employees 2
Industries Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Macrobian Biotech. To contact Macrobian Biotech, visit macrobianbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Macrobian Biotech compare?

A PDF of Macrobian Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Macrobian Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Macrobian Biotech

Macrobian Biotech is a biotechnology startup founded in May 2017 with a mission to advance the field of molecular neuroscience and develop innovative treatments for Parkinson's disease. Founded by Dr. Lars van der Heide and Prof. dr. Marten Smidt, both possessing extensive experience in the field, the company aims to address the urgent need for more effective solutions for this chronic disorder that impacts millions worldwide. Their dedication to improving patients' quality of life has led to the establishment of Macrobian Biotech, currently located at the Amsterdam Science Park, a hub of academic excellence in the Netherlands. The startup's focus on biotechnology and health care aligns with the growing demand for innovative medical treatments. The most recent investment, a Pre Seed Round investment, was secured on May 15, 2017 and was backed by UvA VUmc AMC HvA Ventures Holding BV. This demonstrates not only the potential of Macrobian Biotech but also the confidence of investors in the founders' expertise and the company's vision. As the startup continues to make strides in the biotech industry, its contributions towards addressing Parkinson's disease are certainly worth following.

Business keywords: Neuroscience, Drug Development, Parkinson's Disease, Molecular Research, Innovative Treatments, Academic Excellence, Netherlands, Science Park, Startup, Neurological Disorders, Medical Research, Quality of Life, Innovation, Founders

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
UvA VUmc AMC HvA Ventures Holding BV
UvA VUmc AMC HvA Ventures Holding BV
15 May 2017
Pre Seed Round Undisclosed 1
ACE (Amsterdam Center for Entrepreneurship)
ACE (Amsterdam Center for Entrepreneurship)
01 Feb 2017

Macrobian Biotech Alternatives & Competitors

View All Alternatives
Macrobian Biotech vs
Corlieve Therapeutics
Corlieve Therapeutics France

At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurologic...

Seed
1 employees
Biotechnology, Health Care
Macrobian Biotech vs
Cadent Therapeutics
Cadent Therapeutics

Pioneering precision neuroscience to restore cognitive and motor function through groundbreaking med...

Series B
Biotechnology, Health Care
Macrobian Biotech vs
XWPharma
XWPharma United States

Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other underserved CNS...

Series C
16 employees
Biotechnology, Health Care
View all alternatives

FAQ About Macrobian Biotech

Towards Novel Treatments for Parkinson's Disease
Macrobian Biotech was founded in 2017.
Macrobian Biotech is headquartered in The Netherlands.
Macrobian Biotech operates in Biotechnology and Health Care. Its work centres on Neuroscience, Drug Development, Parkinson's Disease and Molecular Research.
Macrobian Biotech has approximately 2 employees.
Macrobian Biotech has completed 2 funding rounds. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Macrobian Biotech include Corlieve Therapeutics, Cadent Therapeutics, XWPharma, Charco, Newron Pharmaceuticals SpA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Macrobian Biotech and Corlieve Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Macrobian Biotech, https://bouncewatch.com/company/macrobian-biotech, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes